MOSCOW (MRC) -- Huntsman has appointed Phil Lister as executive vice president and Chief Financial Officer (CFO), effective 1 July, as per the company's press release.
He will replace longtime company veteran Sean Douglas, who resigned to accept a full-time calling to The Church of Jesus Christ of Latter-day Saints.
Lister began his career at Imperial Chemical, which Huntsman acquired in 1999. In his most recent role at Huntsman, Lister managed the company’s acquisition and dispositions. The company said that the transactions he oversaw have led to the execution of Huntsman key strategic initiatives.
These transactions, valued at more than USD3.5 billion, have resulted in a significant transformation of the company's portfolio.
"As the head of M&A, Phil has been instrumental in executing the company's portfolio management strategy. He has completed seven transactions in the past three years, that have allowed us to focus further downstream and on our specialty businesses, reduce our debt, strengthen our balance sheet, and improve our trading multiple,” said CEO Peter Huntsman.
As MRC reported before, in early April, 2021, Huntsman Corporation announced that Sean Douglas, 56, had notified the company he intends to resign as Executive Vice President and CFO. The effective date of Mr. Douglas' resignation will be July 1, 2021.
We remind that in late December, 2020, SK Capital Partners completed the acquisition of a 39.75% stake, roughly 42.4 million shares, in titanium dioxide maker Venator from Huntsman for roughly USD100 million. The deal includes a 30-month option for the purchase of Huntsman’s remaining approximate 9.5 million shares by SK at US2.15/share. Huntsman spun off Venator in a 2017 initial public offering.
Huntsman Corporation is a publicly traded global manufacturer and marketer of differentiated and specialty chemicals with 2019 revenues of approximately USD7 billion. The company's chemical products number in the thousands and are sold worldwide to manufacturers serving a broad and diverse range of consumer and industrial end markets. The company operates more than 70 manufacturing, R&D and operations facilities in approximately 30 countries and employ approximately 9,000 associates within our four distinct business divisions.
MRC